US Stomach Cancer Therapeutics Market Size, Share and Growth Forecast 2025–2034
The United States is a major contributor to the stomach cancer therapeutics market, driven by strong investments in oncology research, increasing adoption of precision medicine, and widespread availability of advanced cancer treatments. The presence of leading pharmaceutical companies, growing use of immunotherapies, and a well-established healthcare infrastructure continue to support market...
0 Комментарии 0 Поделились 30 Просмотры 0 предпросмотр